50 Ways To Get Tax-Free Cash Or Benefits –And Leave The IRS Behind

From everyday perks to little-known exemptions, here are 50 ways that the U.S. tax code lets you keep more of your money.

Winklevoss’ Gemini Sued By Shareholders As Stock Plunges

Gemini stock is down 82% from its public debut six months ago as the company reported widening losses and major business changes, prompting a lawsuit from shareholders.

Next Billion-Dollar Startups 2026: Nominations Are Open

For the 12th annual Forbes Next Billion-Dollar Startups list, we’re on the hunt for 25 fast-growing companies most likely to become unicorns — and thrive well beyond that.

AI Optics Boom Propels Founder Of Photonic Chip Maker Into The Billionaire Ranks

Huawei-backed Yuanjie Semiconductor Technology makes photonic chips used in optical interconnects in AI data centers.

This Ex-Palantir Exec Built A $900 Million Privacy-First Cell Network

Cape cofounder and CEO John Doyle is seeing rapid revenue growth for his cell network, which deletes call logs and doesn’t collect social security numbers like AT&T and Verizon do.

Tencent To Double AI Investments To $5.2 Billion Amid China’s OpenClaw Frenzy

The Chinese gaming and social media giant has ample resources to pour into AI. During the final three months of last year, revenues grew 13% year-on-year to 194.4 billion yuan ($28 billion).

The $12 Million Medical Fraud That Put Patients At Risk

Prosecutors say that patients at an Alaska-based clinic were underdosed, injected with free or expired drugs, and billed for full doses. Now, the doctor who was calling the shots is going to jail.

These 26-Year-Old Founders Quit DHS And Built A $200 Million AI Cyber Startup

AI is writing more code than humans—and much of it isn’t secure. Corridor’s founders think they’ve found a way to catch the mistakes before attackers do.

This $600 Million AI Startup Is Speeding Up Paperwork So Patients Get Drugs Faster

Latent Health is tapping into the $200 billion market for specialty drugs with AI agents that help doctors convince insurers to more quickly approve drugs and treatments people need.

Why The CDC’s Vaccine Committee Won’t Meet This Week

In this week’s edition of InnovationRx, we look at Roche’s big AI drug development bet, an E. coli outbreak in raw milk cheddar, R1 Therapeutics’ $78 million raise, and more.